NEW STUDY: Sunlight Penetrates the Human Body, Improving Mitochondrial Function and Vision
Just 15 minutes of fully clothed infrared sunlight exposure triggered systemic effects and measurable improvements in vision — even with eyes completely covered.
A new study published in Scientific Reports titled, Longer wavelengths in sunlight pass through the human body and have a systemic impact which improves vision, confirms what animal studies have long suggested: longer wavelengths of sunlight—particularly in the infrared range (830–860 nm)—can penetrate the human body and improve mitochondrial function systemically. Remarkably, even 15 minutes of back exposure (fully clothed) improved vision 24 hours later — without any light entering the eyes.
40 adults (ages 25–63) participated in the study. Researchers first measured sunlight transmission by placing a radiometer against the chest of shirtless participants standing in direct midday sunlight. In a controlled lab setting, subjects were then exposed to 15 minutes of 850 nm near-infrared (NIR) LED light directed at their backs. Visual performance was evaluated before and 24 hours after exposure using color contrast sensitivity tests. To isolate systemic effects from direct eye exposure, a subgroup wore foil-wrapped head coverings to fully block light from reaching the eyes.
Key Findings
Sunlight penetrates the human torso. Infrared wavelengths (especially 850 nm) passed through the chest and back, reaching internal tissues. Peak transmission was observed between 800–875 nm.
Mitochondrial boost to visual function. A single 15-minute exposure to 850 nm light led to a 16% improvement in tritan (blue-yellow) contrast sensitivity and a 9% improvement in protan (red-green) sensitivity 24 hours later — even in dim lighting conditions.
Systemic effect confirmed. In participants whose heads were completely covered with foil (blocking all ocular exposure), tritan sensitivity still improved by 7%, proving that long-wavelength light acts systemically — likely via mitochondrial and cytokine signaling pathways.
Clothing is not a barrier. Even six layers of common garments (T-shirt, shirt, wool sweater) were nearly 100 times more transparent to 850 nm light than to visible light, allowing infrared to reach the skin and tissues underneath.
Built environment warning. Most indoor LED lighting lacks infrared and instead emits sharp peaks in the blue spectrum (400–450 nm), which are known to impair mitochondrial function and elevate oxidative stress, especially in the absence of balancing long wavelengths.
These findings underscore the critical role of full-spectrum sunlight — particularly its infrared components — in maintaining cellular health and sensory function. As modern environments increasingly rely on artificial lighting that omits these beneficial wavelengths, we are depriving our bodies of essential biological signals. Daily exposure to natural sunlight, even through clothing, appears to be a simple yet powerful tool to support mitochondrial health and optimize vision.
BREAKING – First Peer-Reviewed Study Documents Post-Vaccine Magnetism
Magnetism appeared months after mRNA injection—Pfizer “F” lots were disproportionately linked, with proposed mechanisms involving spike-induced iron metabolism disruption.
A series of cases of COVID-19 vaccine-injected patients suffering from iatrogenic magnetism is described. The attachment of massive metallic objects (up to 70 grams) to different parts of the body is a real phenomenon that may present additional health risksif such patients are subjected to magnetic resonance imaging (MRI). The iatrogenic magnetism phenomenon typically appears several months after the injection. More likely, injected DNA plasmids, or modified mRNAs, translated into the spike protein, or into junk peptides formed through frameshifts, may engender proteins with ferromagnetic properties, or may entrap endogenous iron. Importantly, the spike protein has a distant homology to hepcidin, the key regulator of iron metabolism. Redistribution of iron into the brain or other body parts may be causing iatrogenic magnetism. Pfizer vaccine lots starting with the letter “F” may be involved, although we cannot exclude the possibility that Moderna or other manufacturers’ injections may also cause this phenomenon. In our observation, the magnetism may resolve spontaneously or when nicotinamide adenine dinucleotide (NAD+) is applied. Our pilot observation needs to be corroborated in a larger cohort study.
This magnetism is real and appears to be associated with Pfizer lots beginning with the letter ‘F’, although it was observed with the Moderna shot as well but less frequently. Two cases were reduced or resolved with 500mg oral NAD+ per day. Cases are discussed in the article.
Pfizer doesn’t mention the phenomenon and the study authors are calling for independent quality control testing, which frankly should always be done before a new drug or medical device is rolled out, and particularly if people are told they will lose their jobs if they don’t take it!
“We just don’t know what’s in this stuff,” he said. “They’ve been very secretive,” he continued. ~ Dr. Roger Hodkinson, pathologist
The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough! (Part 2)
Carl Tuttle
Hudson, NH, United States
May 21, 2025
Please see the following response to my inquiry previously sent to Dr. Marcia McNutt regarding the National Academies Report “Lyme Infection-Associated Chronic Illnesses”
———- Original Message ———-
From: “Liao, Julie” <JLiao@nas.edu>
To: CARL TUTTLE <runagain@comcast.net>
Date: 05/19/2025 9:47 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses
Good morning,
I am a senior program officer at the National Academies and co-director of the study that produced the report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses. Dr. McNutt shared your message with me, and I am responding on her behalf as a lead staff for the project.
First of all, thank you for your interest in this report and sharing these concerns. The National Academies committee that authored this report is aware of the painful history of disbelief and mistrust in the early days of recognizing and studying persistent symptoms associated with Lyme disease. It is their hope that this report takes the first step toward moving past this history to catalyze actions that prioritize discovery and development of new, effective, safe treatments for people living with these symptoms. To this end, the report explicitly recognizes that Lyme infection-associated chronic illnesses are real, and that these illnesses are debilitating to the health and well-being of many individuals.
Regarding the concern on funding development and use of new antimicrobials, the report recognizes that there may be a multitude of pathogenic mechanisms and calls for exploration of new treatments that can address the different potential pathways leading to these chronic symptoms. This includes pathogen persistence, as well as autoimmunity or other immune dysregulation as a result of Lyme disease.
It is the committee’s hope that new evidence will continue to emerge and advance our collective knowledge and ability to mitigate and one day cure these infection-associated chronic illnesses, including those associated with Lyme disease.
Warm regards,
Julie
Julie Liao, PhD (she/her)
Co-Director
Forum on Microbial Threats
Study on Evidence Base for Lyme-IACI Treatment
Keck 854 | (202) 334-2191
National Academies of Sciences, Engineering, and Medicine
500 Fifth Street, NW
Washington, DC 20001
nationalacademies.org/HMD
Carl Tuttle’s reply:
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Liao, Julie” <JLiao@nas.edu>
Cc: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>, “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/20/2025 10:02 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses
The optimal treatment for Lyme disease has yet to be determined because the focus early on went directly into developing a vaccine. Here are some examples of how other difficult infections have been handled:
It was once believed that rifampin was curative in treating Brucellosis but when symptoms returned doxycycline was added to the mix and when that too failed a third antibiotic, streptomycin was added to the current treatment regimen. [1] [2]
In 1985 the worldwide incidence of leprosy was 6,000,000. Last year, it was 800,000. The only thing that changed was the addition of rifampin to dapsone in the treatment of the disease. Rifampin was added to dapsone because the M leprae were becoming resistant and it was a new antibiotic at that time.
Treatments for multidrug-resistant tuberculosis have been introduced (bedaquiline and delamanid) with more in the pipeline. [3]
A new treatment for recurrent Clostridium difficile was recently studied (bezlotoxumab) for reducing the risk of a repeat infection. [4]
In contrast, oral amoxicillin or doxycycline remains the treatment of choice for treating Lyme disease for over thirty years regardless if debilitating symptoms return. In 1977 Dr. Allen Steere knew that these antibiotics were not effective for all patients[5] but there has been no change in treatment or research to find more effective ways to eradicate the infection in all stages/forms of disease.
At what point in time do we recognize that we are dealing with an antibiotic resistant/tolerant superbug and focus our research on finding new antimicrobials for this life-altering/life-threatening disease as more of the population becomes severely disabled from inappropriately treated Lyme disease.
From your reply: The report recognizes that there may be a multitude of pathogenic mechanisms and calls for exploration of new treatments that can address the different potential pathways leading to these chronic symptoms. This includes pathogen persistence, as well as autoimmunity or other immune dysregulation as a result of Lyme disease.”
Those of us who have studied the mishandling of Lyme disease believe this is just lip service and the real effort will be spent on expensive treatments for the sick and disabled Lyme community still suffering from chronic Lyme; there’s more profit in providing a lifetime of drugs than on a cure and if a chronic relapsing seronegative disease were identified through the proposed “actions” it would end the current vaccine dream overnight because you cannot prove vaccine efficacy in a disease where we do not know who has or does not have the infection; having a curative approach would also give the public an excuse not to take their vaccine. (Let that sink in)
The Evidence is overwhelming that we have been dealing with an antibiotic resistant/tolerant superbug while the so-called science is (mis)used for legalized gaslighting (Follow the science) The IDSA/CDC have defined the disease (= high costs) away so when patients object; MD’s successfully hide behind their definition and guidelines.
I want to make this crystal clear:Suppressing evidence of antibiotic resistance (as well as ignoring these actions) is a crime and the National Academies has been given detailed notice of this atrocity. Questions:
1. Will the search to find new antibiotics [6] be the research priority?
2.Who will be given responsibility for these studies? (certainly not the same researchers who previously received Lyme funding from the CDC/NIH)
A response to this inquiry is requested.
Carl Tuttle
Independent Researcher
Hudson, NH
Cc: Marcia McNutt, President of the National Academy of Sciences and Chair of the National Research Council REFERENCES (PLEASE READ!)
After acute brucellosis infection, symptoms persist in a minority of patients for more than 1 year. Such patients are defined as having chronic brucellosis. Since no objective laboratory methods exist to confirm the presence of chronic disease, these patients suffer delays in both diagnosis and treatment.
2. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. https://www.ncbi.nlm.nih.gov/pubmed/25246401
The doxycycline-streptomycin-rifampin regimen eliminates Brucella DNA more efficiently than doxycycline-streptomycin, which may result in superior long-term clearance of Brucella.
5. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.
Excerpt:
“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”
6. Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic
Raphael B. Stricker, Lorraine Johnson
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Liao, Julie” <JLiao@nas.edu>
Cc: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>, “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/21/2025 8:42 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses
Dr. Liao,
It’s no surprise that the Chair of your committee that published the Consensus Study Report is a vaccinologist. This validates everything I have been reporting about the rush to create a vaccine for Lyme which led to the deliberate mishandling of the disease.
It is obvious that the priority here is still the Lyme vaccine and finding a cure for chronic Lyme is just lip service.
THE GENEVA FOUNDATION
CHAIR OF THE BOARD OF DIRECTORS KENT KESTER, MD, COL (RET.), USA
Again, here is the old 2014 interview with Willy Burgdorfer where he states research must be started over at square one because the same people have been doing the research and coming up with the same results – nothing!
A federal judge ruled this week that the State of Kansas may proceed with its consumer protection lawsuit against Pfizer in state court, rejecting the pharmaceutical company’s effort to move the case to federal jurisdiction under the Public Readiness and Emergency Preparedness (PREP) Act.
The decision could mark a pivotal moment in efforts to hold vaccine manufacturers accountable for how COVID-19 vaccines were marketed to the public.
In his opinion, U.S. District Judge Daniel D. Crabtree ruled that Kansas’ allegations fall outside the scope of the PREP Act, which grants legal immunity to vaccine manufacturers for injury claims tied to federally recommended pandemic countermeasures. Crabtree found that Kansas’ case centers on claims of deceptive marketing practices, not on physical injuries, and therefore is not preempted by the Act.
“That point alone ends the debate,” Crabtree wrote, concluding the case should be remanded to the District Court of Thomas County, where it was originally filed.
The Kansas Lawsuit
On June 17, 2024, Kansas Attorney General Kris Kobach filed suit against Pfizer, alleging the company violated the Kansas Consumer Protection Act by misrepresenting its COVID-19 vaccine as “safe and effective” while concealing evidence of serious risks and diminishing effectiveness over time. The complaint alleges that:
Pfizer did not disclose links between the vaccine and conditions such as myocarditis, pericarditis, pregnancy complications, and deaths;
The company falsely promoted the vaccine’s continued efficacy even as internal data showed its effectiveness waned;
Pfizer misled the public by claiming the vaccine would prevent transmission of the virus, despite never conducting studies to confirm that claim.
The case does not involve injury or wrongful death claims. Instead, it alleges that Pfizer’s communications misled consumers and violated state law. (See link for article and video)
As many are unfortunately keen to forget, in 2020 the world was locked down for the claim of a deadly pandemic that still only exists in words. We were then coerced into taking an experimental mystery shot that genetically alters us and contaminates us with nanotech. In July of 2020, an accomplished class-action lawyer who beat Volkswagen and Deutsche Bank, Reiner Fuëllmich assembled the Corona Committee to help build a case against those responsible for the greatest crimes against humanity.
For a little over three years, Reiner Fuëllmich and his committee collected interviews and testimony from whistle-blowers, experts, and witnesses up until October of 2023, when he was kidnapped in Mexico, deported to Germany, and detained on allegations of embezzlement. After his arrest, committee member, Viviane Fischer, began publicly attacking Fuëllmich.
A leaked dossier from German intelligence instructed agencies to seize control of the Corona Committee, to silence Reiner Fuëllmich, and to disqualify him from running for public office. (See link for 5 min. video and transcript)
_______________
**Comment**
According to this, “Fuëllmich had been more than an eyesore for large enterprises and the German state for decades…
The corona crisis transformed Fuellmich into a potential three-tiered threat to the official corona narrative and the longer term implementation of the Great Reset. Not only did Fuellmich provide, with CIC, an online platform for scientists and experts critical of the government’s corona narrative voiced their views and scientific findings, he made several attempts to get a class action suit going abroad (in New York, New Zealand, South Africa and twice in Canada) to fight governments’ abuse of human rights, the damage caused by corona measures and more specifically, the use of the PCR-test as a diagnostic tool. His third offensive was political, as the national electoral candidate for the newly established political party, Die Basis, in the run up to the German 2022 elections.”
Fuëllmich simply had to go.
It appears that these agencies got to the committee members and used Fischer to complete their tasks. False allegations of embezzlement and the ensuing negative public opinion paint a starkly different picture than the court hearings. This article gives a overview of the (adjusted) charge.
JVA Rosdorf
Dr. Reiner Fuellmich
Am Grossen Sieke 8
37124 Rosdorf Germany
Letters, cards and postcards are allowed
No glitter on the envelope
No stamps or money in the envelope
Do not send books or any other objects, they will be refused
Do not write about the criminal proceedings against Reiner Fuellmich, although scanning on his incoming post seems to have eased up.
Put your name on each page of your letter and number the pages. If they do check the mail, at least Reiner will know the order of your writing and can see if pages are missing.
Madison Area Lyme Support Group 